81 related articles for article (PubMed ID: 25865056)
1. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
[TBL] [Abstract][Full Text] [Related]
2. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
[TBL] [Abstract][Full Text] [Related]
3. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
[TBL] [Abstract][Full Text] [Related]
4. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
[TBL] [Abstract][Full Text] [Related]
5. Plant-derived antivirals against hepatitis c virus infection.
Jardim ACG; Shimizu JF; Rahal P; Harris M
Virol J; 2018 Feb; 15(1):34. PubMed ID: 29439720
[TBL] [Abstract][Full Text] [Related]
6. Strategies for antiviral screening targeting early steps of virus infection.
Peng T
Virol Sin; 2010 Aug; 25(4):281-93. PubMed ID: 20960301
[TBL] [Abstract][Full Text] [Related]
7. Multiple effects of silymarin on the hepatitis C virus lifecycle.
Wagoner J; Negash A; Kane OJ; Martinez LE; Nahmias Y; Bourne N; Owen DM; Grove J; Brimacombe C; McKeating JA; Pécheur EI; Graf TN; Oberlies NH; Lohmann V; Cao F; Tavis JE; Polyak SJ
Hepatology; 2010 Jun; 51(6):1912-21. PubMed ID: 20512985
[TBL] [Abstract][Full Text] [Related]
8. Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1.
Hu Z; Rolt A; Hu X; Ma CD; Le DJ; Park SB; Houghton M; Southall N; Anderson DE; Talley DC; Lloyd JR; Marugan JC; Liang TJ
Cell Chem Biol; 2020 Jul; 27(7):780-792.e5. PubMed ID: 32386595
[TBL] [Abstract][Full Text] [Related]
9. Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.
Pietschmann T
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807238
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.
Graw F; Martin DN; Perelson AS; Uprichard SL; Dahari H
J Virol; 2015 Jul; 89(13):6551-61. PubMed ID: 25833046
[TBL] [Abstract][Full Text] [Related]
11. Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.
Yu X; Uprichard SL
Curr Protoc Microbiol; 2010 Aug; Chapter 17(1):Unit 17.5.. PubMed ID: 20812217
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis reveals effects of bioactive ingredients from
Zhao H; Wang S; Zhou Y; Ertay A; Williamson PTF; Ewing RM; Tang X; Wang J; Wang Y
Front Plant Sci; 2022; 13():994036. PubMed ID: 36388517
[No Abstract] [Full Text] [Related]
13. The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.
Sabahi A; Marsh KA; Dahari H; Corcoran P; Lamora JM; Yu X; Garry RF; Uprichard SL
Virology; 2010 Nov; 407(1):110-9. PubMed ID: 20800257
[TBL] [Abstract][Full Text] [Related]
14. Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection.
Zhang W; Liu S; Maiga RI; Pelletier J; Brown LE; Wang TT; Porco JA
J Am Chem Soc; 2019 Jan; 141(3):1312-1323. PubMed ID: 30590924
[TBL] [Abstract][Full Text] [Related]
15.
Wahyuni TS; Sukma NS; Permanasari AA; Aoki-Utsubo C; Widyawaruyanti A; Hafid AF
F1000Res; 2022; 11():1452. PubMed ID: 38046541
[No Abstract] [Full Text] [Related]
16. Aqueous extracts of the marine brown alga Lobophora variegata inhibit HIV-1 infection at the level of virus entry into cells.
Kremb S; Helfer M; Kraus B; Wolff H; Wild C; Schneider M; Voolstra CR; Brack-Werner R
PLoS One; 2014; 9(8):e103895. PubMed ID: 25144758
[TBL] [Abstract][Full Text] [Related]
17. Flunarizine arrests hepatitis C virus membrane fusion.
Prigozhin DM; Modis Y
Hepatology; 2016 Jan; 63(1):14-6. PubMed ID: 26389725
[No Abstract] [Full Text] [Related]
18. Time-of-addition and Temperature-shift Assays to Determine Particular Step(s) in the Viral Life Cycle that is Blocked by Antiviral Substance(s).
Aoki-Utsubo C; Chen M; Hotta H
Bio Protoc; 2018 May; 8(9):e2830. PubMed ID: 34286039
[TBL] [Abstract][Full Text] [Related]
19. Host cell kinases and the hepatitis C virus life cycle.
Colpitts CC; Lupberger J; Doerig C; Baumert TF
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1657-62. PubMed ID: 25896387
[TBL] [Abstract][Full Text] [Related]
20. The missing pieces of the HCV entry puzzle.
Ogden SC; Tang H
Future Virol; 2015; 10(4):415-428. PubMed ID: 25960762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
